Dr. Lee on the Importance of Collaboration in Precision Medicine


In Partnership With:

Kelvin P. Lee, MD, discusses the importance of collaboration in precision medicine.

Kelvin P. Lee, MD, senior associate dean of Cancer Research, director, Indiana University (IU) Simon Comprehensive Cancer Center, H.H. Gregg professor of oncology, member, the Department of Medicine, the Department of Microbiology and Immunology, IU School of Medicine, Indiana University Health, discusses the importance of collaboration in precision medicine.

At the IU Simon Comprehensive Cancer Center, a precision medicine team takes patient referrals to receive testing and sequencing, Lee says. The team then analyzes the results to identify abnormalities and mutations that could lead to actionable treatment, Lee adds. This process is beneficial because multiple experts gather in one room to discuss the best course of action, Lee explains.

With the addition of a virtual option for these meetings, there is the benefit of adding moving precision medicine out into the community, Lee continues. Utilizing the virtual option can allow the team to reach more patients, plus more primary care physicians or community oncologists, to get referrals and assist in treatment decisions, Lee concludes.

Related Videos
Jaime R. Merchán, MD, Sylvester Comprehensive Cancer Center
Rona Yaeger, MD
Jeremy L. Ramdial, MD, assistant professor, Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Alexandra Gomez Arteaga, MD, Weill Cornell Medicine/New York-Presbyterian Hospital
Rahul Banerjee, MD, FACP, assistant professor, Clinical Research Division, Fred Hutchinson Cancer Center; assistant professor, Division of Hematology and Oncology, University of Washington
Alice Bertaina, MD, PhD
Jeffery Auletta, MD, The Ohio State University College of Medicine
Betty Hamilton, MD, Cleveland Clinic
Stephanie Lee, MD, MPH, Fred Hutchinson Cancer Center
Chul Kim, MD, MPH